these results revealed a significant difference in the subpopulations of mucosal lymphocytes in the involved sites in the active stage of uc as compared to normal controls , suggesting that immunological abnormalities may be implicated in the etiology of this disease and that disease remission on salazosulfapyridine treatment is associated with a correction of the colonic lymphocyte abnormalities .
C0009324
uc
C0036078
salazosulfapyridine